Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry R Stouch

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|June 9, 2006
Human PEPT1 pharmacophore distinguishes between dipeptide transport and bindingBalvinder S Vig, Terry R Stouch, Julita K Timoszyk, et al.
Molecular Pharmaceutics|April 19, 2005
A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonistsTeresa N Faria, Julita K Timoszyk, Terry R Stouch, et al.
Journal of Molecular Graphics & Modelling|June 12, 2003
Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for successAndrew C Good, Daniel L Cheney, Doree F Sitkoff, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)Richard Sulsky, David R Magnin, Yanting Huang, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of GlaucomaBryce A Harrison, Zheng Y Almstead, Hugh Burgoon, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitorsTheodore C Jessop, James E Tarver, Marianne Carlsen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|June 9, 2006
Human PEPT1 pharmacophore distinguishes between dipeptide transport and bindingBalvinder S Vig, Terry R Stouch, Julita K Timoszyk, et al.
Molecular Pharmaceutics|April 19, 2005
A novel high-throughput pepT1 transporter assay differentiates between substrates and antagonistsTeresa N Faria, Julita K Timoszyk, Terry R Stouch, et al.
Journal of Molecular Graphics & Modelling|June 12, 2003
Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for successAndrew C Good, Daniel L Cheney, Doree F Sitkoff, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)Richard Sulsky, David R Magnin, Yanting Huang, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of GlaucomaBryce A Harrison, Zheng Y Almstead, Hugh Burgoon, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitorsTheodore C Jessop, James E Tarver, Marianne Carlsen, et al.
Pageof 2